Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer.
Parekh A, Chen MH, D'Amico AV, Dosoretz DE, Ross R, Salenius S, Graham PL, Beckman JA, Beard CJ, Choueiri TK, Ennis RD, Hoffman KE, Hu JC, Ma J, Martin NE, Nguyen PL.
Parekh A, et al. Among authors: nguyen pl.
Brachytherapy. 2013 Sep-Oct;12(5):415-21. doi: 10.1016/j.brachy.2013.02.005. Epub 2013 May 4.
Brachytherapy. 2013.
PMID: 23651926